We present findings from a longitudinal ethnographic study of infertile couples seeking treatment following initial GP referral to specialist fertility services. Repeated observations and interviews were undertaken with the same 14 heterosexual participants over an 18‐month period. Heterosexual, non‐donor couples comprise the majority of fertility clinic patients; however, research interest in this group has dwindled over time as IVF cycles have increased. In the United Kingdom, IVF is presented as a logical response to involuntary childlessness, and as an entirely predictable, and linear, course of action. The market is well‐developed and often patients' first experience of privatised health care in the NHS. Our couples were challenged by ...
Dementia is one of the most disabling health conditions in older people. Increasing attention is pai...
Cisplatin is effective against many types of carcinoma. However, a high rate of renal damage is a cl...
Clofarabine is an active antileukemic drug for subgroups of patients with acute myeloid leukemia (AM...
The safety of novel therapeutics and vaccines are typically assessed in early phase clinical trials ...
Following the 'Swiss statement' in 2008 it became an option to omit the use of condoms in serodiscor...
Moxidectin is a frontrunner drug candidate in the treatment of strongyloidiasis. A dose of 8 mg is r...
There are contrasting findings regarding the effect of HIV on the pharmacokinetics of first-line ant...
Objective: This study aimed at evaluating the safety of administering immune checkpoint inhibitors ...
This is an open access article under the terms of the Creative Commons Attribution License, which pe...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
Background: Neuropathic pain symptoms and signs of increased pain sensitization in osteoarthritis (O...
Using interview and observational data from a busy and research-intensive breast cancer service in t...
Regenerative endodontic treatment such as revitalization provides a treatment option for immature te...
Objective: Polypharmacy and overprescription of off-label medications are common in patients with ...
Altres ajuts: acords transformatius de la UABObjective: Polypharmacy and overprescription of off-lab...
Dementia is one of the most disabling health conditions in older people. Increasing attention is pai...
Cisplatin is effective against many types of carcinoma. However, a high rate of renal damage is a cl...
Clofarabine is an active antileukemic drug for subgroups of patients with acute myeloid leukemia (AM...
The safety of novel therapeutics and vaccines are typically assessed in early phase clinical trials ...
Following the 'Swiss statement' in 2008 it became an option to omit the use of condoms in serodiscor...
Moxidectin is a frontrunner drug candidate in the treatment of strongyloidiasis. A dose of 8 mg is r...
There are contrasting findings regarding the effect of HIV on the pharmacokinetics of first-line ant...
Objective: This study aimed at evaluating the safety of administering immune checkpoint inhibitors ...
This is an open access article under the terms of the Creative Commons Attribution License, which pe...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
Background: Neuropathic pain symptoms and signs of increased pain sensitization in osteoarthritis (O...
Using interview and observational data from a busy and research-intensive breast cancer service in t...
Regenerative endodontic treatment such as revitalization provides a treatment option for immature te...
Objective: Polypharmacy and overprescription of off-label medications are common in patients with ...
Altres ajuts: acords transformatius de la UABObjective: Polypharmacy and overprescription of off-lab...
Dementia is one of the most disabling health conditions in older people. Increasing attention is pai...
Cisplatin is effective against many types of carcinoma. However, a high rate of renal damage is a cl...
Clofarabine is an active antileukemic drug for subgroups of patients with acute myeloid leukemia (AM...